True Wealth Design’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-39
Closed -$224 – 2728
2026
Q2
$224 Sell
39
-21
-35% -$121 ﹤0.01% 2423
2026
Q1
$377 Buy
60
+46
+329% +$427 ﹤0.01% 2149
2025
Q4
$172 Hold
14
– – ﹤0.01% 2259
2025
Q3
$287 Hold
14
– – ﹤0.01% 2203
2025
Q2
$189 Buy
14
+4
+40% +$44 ﹤0.01% 2092
2025
Q1
$87 Buy
+10
New +$61 ﹤0.01% 2241

Other funds holding OPRX

True Wealth Design's OPRX Position: Q3 2026 in Review

True Wealth Design sold out of OptimizeRx (OPRX) in Q3 2026, closing a stake of 39 shares — an estimated $224 sold.

True Wealth Design first reported a position in OPRX in Q1 2025 and held it in 6 quarters. The position peaked at $377 in Q1 2026. 9 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.

  • True Wealth Design reported no remaining OptimizeRx position as of Q3 2026 after selling out during the quarter.
  • True Wealth Design sold 39 OptimizeRx shares in Q3 2026, an estimated $224.
  • True Wealth Design first reported a position in OptimizeRx in Q1 2025 and held it in 6 quarters.
  • True Wealth Design's OptimizeRx position peaked at $377 in Q1 2026.
  • 9 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.